Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Physician Agency and Patient Survival.

Jacobson MG, Chang TY, Earle CC, Newhouse JP.

J Econ Behav Organ. 2017 Feb;134:27-47. doi: 10.1016/j.jebo.2016.11.011. Epub 2016 Dec 2.

PMID:
28133401
2.

A Validation Study of Administrative Claims Data to Measure Ovarian Cancer Recurrence and Secondary Debulking Surgery.

Livaudais-Toman J, Egorova N, Franco R, Prasad-Hayes M, Howell EA, Wisnivesky J, Bickell NA.

EGEMS (Wash DC). 2016 Nov 1;4(1):1208. eCollection 2016.

3.

Care in the Final Month of Life among Adolescent and Young Adult Cancer Patients in Kaiser Permanente Southern California.

Mack JW, Cannavale K, Sattayapiwat O, Cheung B, Chen LH, Cooper RM, Chao CR.

J Palliat Med. 2016 Nov;19(11):1136-1141. Epub 2016 Aug 2.

PMID:
27482745
4.

The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data.

Sherer EA, Fisher DA, Barnd J, Jackson GL, Provenzale D, Haggstrom DA.

BMC Health Serv Res. 2016 Feb 11;16:50. doi: 10.1186/s12913-016-1294-9.

5.

Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population.

Cummings LC, Kou TD, Schluchter MD, Chak A, Cooper GS.

Gastrointest Endosc. 2016 Aug;84(2):232-240.e1. doi: 10.1016/j.gie.2016.01.019. Epub 2016 Jan 19.

PMID:
26801375
6.

End-of-Life Care Intensity Among Adolescent and Young Adult Patients With Cancer in Kaiser Permanente Southern California.

Mack JW, Chen LH, Cannavale K, Sattayapiwat O, Cooper RM, Chao CR.

JAMA Oncol. 2015 Aug;1(5):592-600. doi: 10.1001/jamaoncol.2015.1953.

7.

Challenges and opportunities in measuring cancer recurrence in the United States.

Warren JL, Yabroff KR.

J Natl Cancer Inst. 2015 May 12;107(8). pii: djv134. doi: 10.1093/jnci/djv134. Print 2015 Aug.

8.

Development of a claims-based algorithm to identify colorectal cancer recurrence.

Deshpande AD, Schootman M, Mayer A.

Ann Epidemiol. 2015 Apr;25(4):297-300. doi: 10.1016/j.annepidem.2015.01.005. Epub 2015 Jan 16.

9.

The diffusion of docetaxel in patients with metastatic prostate cancer.

Unger JM, Hershman DL, Martin D, Etzioni RB, Barlow WE, LeBlanc M, Ramsey SR.

J Natl Cancer Inst. 2014 Dec 24;107(2). pii: dju412. doi: 10.1093/jnci/dju412. Print 2015 Feb.

10.

Considerations for observational research using large data sets in radiation oncology.

Jagsi R, Bekelman JE, Chen A, Chen RC, Hoffman K, Shih YC, Smith BD, Yu JB.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):11-24. doi: 10.1016/j.ijrobp.2014.05.013. Review.

11.

An algorithm to identify the development of lymphedema after breast cancer treatment.

Yen TW, Laud PW, Sparapani RA, Li J, Nattinger AB.

J Cancer Surviv. 2015 Jun;9(2):161-71. doi: 10.1007/s11764-014-0393-z. Epub 2014 Sep 4.

12.

Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?

Kemp A, Preen DB, Saunders C, Boyle F, Bulsara M, Malacova E, Roughead EE.

Springerplus. 2014 Jun 4;3:282. doi: 10.1186/2193-1801-3-282. eCollection 2014.

13.

A comparison of the effects of epidural analgesia versus traditional pain management on outcomes after gastric cancer resection: a population-based study.

Cummings KC 3rd, Patel M, Htoo PT, Bakaki PM, Cummings LC, Koroukian S.

Reg Anesth Pain Med. 2014 May-Jun;39(3):200-7. doi: 10.1097/AAP.0000000000000079.

14.

Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.

Warren JL, Mariotto A, Melbert D, Schrag D, Doria-Rose P, Penson D, Yabroff KR.

Med Care. 2016 Aug;54(8):e47-54. doi: 10.1097/MLR.0000000000000058.

PMID:
24374419
15.

Preoperative breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study.

Fortune-Greeley AK, Wheeler SB, Meyer AM, Reeder-Hayes KE, Biddle AK, Muss HB, Carpenter WR.

Breast Cancer Res Treat. 2014 Jan;143(1):203-12. doi: 10.1007/s10549-013-2787-4. Epub 2013 Dec 4.

16.

Survival impact of followup care after radical cystectomy for bladder cancer.

Strope SA, Chang SH, Chen L, Sandhu G, Piccirillo JF, Schootman M.

J Urol. 2013 Nov;190(5):1698-703. doi: 10.1016/j.juro.2013.05.051. Epub 2013 May 29.

17.

Unsupported off-label chemotherapy in metastatic colon cancer.

de Souza JA, Polite B, Perkins M, Meropol NJ, Ratain MJ, Newcomer LN, Alexander GC.

BMC Health Serv Res. 2012 Dec 29;12:481. doi: 10.1186/1472-6963-12-481.

18.

Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.

Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, Schrag D, Warren JL, Hornbrook MC, Weeks JC.

Med Care. 2014 Oct;52(10):e65-73. doi: 10.1097/MLR.0b013e318277eb6f.

19.

Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer.

Chubak J, Yu O, Pocobelli G, Lamerato L, Webster J, Prout MN, Ulcickas Yood M, Barlow WE, Buist DS.

J Natl Cancer Inst. 2012 Jun 20;104(12):931-40. doi: 10.1093/jnci/djs233. Epub 2012 Apr 30.

20.

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

Ritzwoller DP, Carroll N, Delate T, O'Keeffe-Rossetti M, Fishman PA, Loggers ET, Aiello Bowles EJ, Elston-Lafata J, Hornbrook MC.

Med Care. 2013 Oct;51(10):e67-73. doi: 10.1097/MLR.0b013e31824def85.

Supplemental Content

Support Center